Concepts (228)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- 3',5'-Cyclic-GMP Phosphodiesterases
- Adiposity
- Adrenal Cortex Hormones
- Adrenal Gland Neoplasms
- Adrenergic beta-Antagonists
- Adult
- African Americans
- Age Factors
- Aged
- Aged, 80 and over
- Aging
- Aldosterone
- Algorithms
- Aminobutyrates
- Amputation
- Angiopoietin-like Proteins
- Angiotensin II Type 1 Receptor Blockers
- Angiotensin Receptor Antagonists
- Angiotensin-Converting Enzyme Inhibitors
- Animals
- Ankle Brachial Index
- Anti-Bacterial Agents
- Antibodies, Monoclonal
- Anticholesteremic Agents
- Antihypertensive Agents
- Anti-Inflammatory Agents
- Antioxidants
- Antiviral Agents
- Arterial Pressure
- Asia
- Atherosclerosis
- Athletes
- Azepines
- Benzhydryl Compounds
- Betacoronavirus
- Biomarkers
- Biphenyl Compounds
- Blood Glucose
- Blood Pressure
- Blood Pressure Determination
- Blood Pressure Monitoring, Ambulatory
- Canagliflozin
- Cardiorespiratory Fitness
- Cardiovascular Agents
- Cardiovascular Diseases
- Cardiovascular System
- Carotid Arteries
- Carotid Intima-Media Thickness
- Cause of Death
- Cerebrovascular Disorders
- Cholagogues and Choleretics
- Cholesterol, LDL
- Clinical Trials as Topic
- Cohort Studies
- Communicable Disease Control
- Comorbidity
- Coronavirus
- Coronavirus Infections
- C-Reactive Protein
- Critical Care
- Cross-Sectional Studies
- Cyclic Nucleotide Phosphodiesterases, Type 5
- Decision Support Techniques
- Delivery of Health Care
- Denervation
- Diabetes Complications
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Ketoacidosis
- Diabetic Nephropathies
- Diffusion of Innovation
- Dipeptidyl Peptidase 4
- Dipeptidyl-Peptidase IV Inhibitors
- Diuretics
- Double-Blind Method
- Dreams
- Drug Combinations
- Drug Interactions
- Drug Resistance
- Drug Therapy, Combination
- Dyslipidemias
- Echocardiography
- Electronic Health Records
- Epidemics
- Erectile Dysfunction
- Europe
- Evidence-Based Medicine
- Exercise
- Exercise Tolerance
- Ezetimibe
- Fatty Acids, Unsaturated
- Fatty Liver
- Female
- Fenofibrate
- Fibrin
- Follow-Up Studies
- Forecasting
- Friends
- Gastroenterology
- Glucagon-Like Peptide-1 Receptor
- Glucocorticoids
- Glucose
- Glucosides
- Glycated Hemoglobin A
- Government
- Greece
- Heart Failure
- Heart Ventricles
- Hematocrit
- Hemodynamics
- Hemoglobins
- Hormone Replacement Therapy
- Humans
| - Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hyperaldosteronism
- Hyperlipoproteinemia Type II
- Hypertension
- Hypertension, Renovascular
- Hypertrophy, Left Ventricular
- Hypoglycemic Agents
- Hypogonadism
- Hypokalemia
- Hypolipidemic Agents
- Immunoglobulins, Intravenous
- Incidence
- Insulin
- Insulin Glargine
- Insulin Resistance
- Interleukin 1 Receptor Antagonist Protein
- Intracranial Hemorrhages
- Janus Kinase Inhibitors
- Kaplan-Meier Estimate
- Kidney
- Life Style
- Lipid Metabolism
- Lipids
- Lipoproteins, HDL
- Liraglutide
- Liver
- Liver Diseases
- Longitudinal Studies
- Long-Term Care
- Male
- Mass Screening
- Medication Adherence
- Metabolic Syndrome
- Middle Aged
- Mineralocorticoid Receptor Antagonists
- Mortality
- Mutation
- Naphthyridines
- Neprilysin
- Non-alcoholic Fatty Liver Disease
- North America
- Obesity
- Observational Studies as Topic
- Office Visits
- Pandemics
- Penile Erection
- Peptides
- Phosphodiesterase Inhibitors
- Phosphoric Diester Hydrolases
- Placebos
- Pneumonia, Viral
- Polypharmacy
- Practice Guidelines as Topic
- Prediabetic State
- Predictive Value of Tests
- Preoperative Care
- Prevalence
- Primary Prevention
- Prognosis
- Proportional Hazards Models
- Proprotein Convertase 9
- Prospective Studies
- Protein Kinase Inhibitors
- Psoriasis
- Pulse Wave Analysis
- Randomized Controlled Trials as Topic
- Receptors, LDL
- Receptors, Urokinase Plasminogen Activator
- Renal Artery
- Renal Artery Obstruction
- Renal Insufficiency, Chronic
- Renin
- Renin-Angiotensin System
- Reproducibility of Results
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Risk Reduction Behavior
- RNA, Messenger
- Rosuvastatin Calcium
- Secondary Prevention
- Serine Proteinase Inhibitors
- Serum Amyloid P-Component
- Sexual Behavior
- Sleep Apnea, Obstructive
- Sleep Initiation and Maintenance Disorders
- Socioeconomic Factors
- Sodium
- Sodium-Glucose Transporter 2
- Spironolactone
- Stroke
- Stroke Volume
- Survival Analysis
- Sweden
- Sympathectomy
- Symporters
- Systole
- Telemedicine
- Testosterone
- Tetrazoles
- Thiazolidinediones
- Thinness
- Thrombosis
- Time Factors
- Treatment Outcome
- Triazoles
- United States
- United States Department of Veterans Affairs
- Valsartan
- Vascular Stiffness
- Venoms
- Ventricular Dysfunction, Right
- Ventricular Function, Right
- Veterans
|
Doumas's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(228)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(81)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_